Central Illustration.

Common Cardiovascular Effects of BTK Inhibitor Treatment in the Patient With Hematologic Malignancy

∗Symptom (eg, palpitations, shortness of breath, chest pain) triggered Holter monitoring strategy is suggested for patients treated with BTK inhibitor therapies. ACEi = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; ARNI = angiotensin receptor neprilysin inhibitor; BP = blood pressure; BTK = Bruton’s tyrosine kinase; DOAC = direct oral anticoagulant; HF = heart failure; SGLT2i = sodium/glucose cotransporter-2 inhibitor.